Iambic Therapeutics
Iambic Therapeutics is a clinical-stage AI drug discovery company headquartered in San Diego. Its proprietary AI platform pairs the NeuralPLexer 3D generative model for protein-ligand structure prediction with the Enchant multimodal transformer for clinical and preclinical endpoint prediction, integrated with automated wet-lab capabilities. Iambic's clinical pipeline includes IAM1363 (HER2), IAM-K1 (KIF18A), and IAM-C1 (CDK2/4) in oncology. Iambic is a therapeutics developer rather than an API provider and does not publish a public developer API or open-source platform.
Index entry only — little beyond a description and a link, and nothing machine-readable enough for an agent to act on without a human reading the site first.
API Evangelist profiles Iambic Therapeutics the way a machine reads it — 8 machine-readable artifacts, pulled from the provider's own public surface and indexed so a developer, an analyst, or an AI agent can evaluate it against every other provider on the network.
Every provider in the network is reduced to the same set of machine-readable artifacts — OpenAPI contracts, event specifications, GraphQL schemas, runnable collections, pricing and rate-limit signals, security posture, OAuth scopes, and the agent surfaces (MCP servers and skills) that let software drive the API on its own. We profile them because the interface is the part of a company you can actually inspect: it is a truer signal of what a provider does than any marketing page. From those artifacts we compute the Kin Score — Iambic Therapeutics scores 10.9/100 (minimal), with a separate agent-readiness read of 10/100 (human only). The full breakdown is below, followed by every artifact we hold — each card links through to its machine-readable definition on apis.io.
Kin Score
This is the API Evangelist rating — a single, repeatable read computed from the artifacts on this page. Green fill is points earned; the red track is points possible, so every bar shows earned-versus-possible at a glance.
Kin Score
How this is scored →scored 2026-07-27 · rubric v0.5
How we profile Iambic Therapeutics
Each block below is one kind of artifact we hold for Iambic Therapeutics. For each we say what it is and why it earns a place in the profile, then list every one we've indexed — capped at two rows, scroll within the panel for the rest.
Features 4
The notable capabilities this provider advertises, captured as structured features so they can be searched and compared instead of read one landing page at a time.
Notable capabilities this provider offers.
NeuralPLexer
3D generative model that predicts protein-ligand complex structures directly from amino acid sequence and ligand graph inputs, reported in Nature Machine Intelligence with state...
Enchant
Multimodal transformer that predicts clinical and preclinical endpoints from molecular structures.
Automated Wet-Lab Integration
Closed-loop coupling of AI design with high-throughput automated wet-lab synthesis and assay capabilities.
Brain-Penetrant Small Molecules
Programs such as IAM1363 designed to cross the blood-brain barrier for CNS and brain-metastatic oncology indications.
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals — the evidence that a provider takes security seriously enough to document it. We profile it because you can't govern what you can't see.
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Use Cases 3
What developers actually build with this provider — captured so the catalogue answers 'what is this for', not just 'what does this expose'.
What developers build with this provider.
AI-Driven Small-Molecule Design
End-to-end design of novel small-molecule therapeutics using generative AI.
Protein-Ligand Structure Prediction
Structural prediction to support hit discovery and lead optimization.
Clinical Endpoint Prediction
Machine-learning prediction of preclinical and clinical endpoints to guide program selection.
Resources
Every other property we hold for Iambic Therapeutics — documentation, portals, status pages, policies, and corporate surface — grouped by the job it does, following the integrator's arc from getting started to running in production.
Access & Security 3
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Company 7
The organization behind the API
Scroll within the panel for all 7 ·
Other 7
Properties that don't map to a standard resource type
Scroll within the panel for all 7 ·
← All providers · Data indexed from github.com/api-evangelist/iambic · machine-readable index on apis.io